Annual CFO
-$103.76 M
+$7.44 M+6.69%
December 31, 2023
Summary
- As of February 6, 2025, ITOS annual cash flow from operations is -$103.76 million, with the most recent change of +$7.44 million (+6.69%) on December 31, 2023.
- During the last 3 years, ITOS annual CFO has fallen by -$78.58 million (-312.12%).
- ITOS annual CFO is now -120.22% below its all-time high of $513.14 million, reached on December 31, 2021.
Performance
ITOS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$37.35 M
-$3.42 M-10.09%
September 30, 2024
Summary
- As of February 6, 2025, ITOS quarterly cash flow from operations is -$37.35 million, with the most recent change of -$3.42 million (-10.09%) on September 30, 2024.
- Over the past year, ITOS quarterly CFO has dropped by -$23.59 million (-171.35%).
- ITOS quarterly CFO is now -106.17% below its all-time high of $605.00 million, reached on September 30, 2021.
Performance
ITOS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$117.44 M
-$3.46 M-3.04%
September 30, 2024
Summary
- As of February 6, 2025, ITOS TTM cash flow from operations is -$117.44 million, with the most recent change of -$3.46 million (-3.04%) on September 30, 2024.
- Over the past year, ITOS TTM CFO has dropped by -$13.69 million (-13.19%).
- ITOS TTM CFO is now -120.73% below its all-time high of $566.49 million, reached on September 30, 2021.
Performance
ITOS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ITOS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | -171.3% | -13.2% |
| 3 y3 years | -312.1% | -106.2% | -120.7% |
| 5 y5 years | -443.3% | -573.7% | -407.4% |
ITOS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -120.2% | +6.7% | -171.3% | +36.5% | -122.9% | +17.8% |
| 5 y | 5-year | -120.2% | +6.7% | -106.2% | +36.5% | -120.7% | +17.8% |
| alltime | all time | -120.2% | +6.7% | -106.2% | +36.5% | -120.7% | +17.8% |
ITeos Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$37.35 M(+10.1%) | -$117.44 M(+3.0%) |
| Jun 2024 | - | -$33.93 M(+4.7%) | -$113.98 M(+4.0%) |
| Mar 2024 | - | -$32.40 M(+135.4%) | -$109.60 M(+5.6%) |
| Dec 2023 | -$103.76 M(-6.7%) | -$13.77 M(-59.4%) | -$103.76 M(-11.4%) |
| Sep 2023 | - | -$33.89 M(+14.7%) | -$117.16 M(+3.7%) |
| Jun 2023 | - | -$29.55 M(+11.3%) | -$112.97 M(-0.7%) |
| Mar 2023 | - | -$26.55 M(-2.3%) | -$113.75 M(+2.3%) |
| Dec 2022 | -$111.19 M(-121.7%) | -$27.17 M(-8.5%) | -$111.19 M(-22.2%) |
| Sep 2022 | - | -$29.70 M(-2.1%) | -$142.84 M(-129.0%) |
| Jun 2022 | - | -$30.32 M(+26.3%) | $491.86 M(-2.4%) |
| Mar 2022 | - | -$24.00 M(-59.2%) | $503.93 M(-1.8%) |
| Dec 2021 | $513.14 M | -$58.82 M(-109.7%) | $513.14 M(-9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $605.00 M(-3414.2%) | $566.49 M(-1262.3%) |
| Jun 2021 | - | -$18.25 M(+23.4%) | -$48.74 M(+20.4%) |
| Mar 2021 | - | -$14.79 M(+170.7%) | -$40.49 M(+60.8%) |
| Dec 2020 | -$25.18 M(+8.8%) | -$5.46 M(-46.6%) | -$25.18 M(-5.5%) |
| Sep 2020 | - | -$10.23 M(+2.3%) | -$26.66 M(+21.3%) |
| Jun 2020 | - | -$10.00 M(-2019.8%) | -$21.97 M(+23.4%) |
| Mar 2020 | - | $521.00 K(-107.5%) | -$17.81 M(-23.1%) |
| Dec 2019 | -$23.14 M(+21.2%) | -$6.94 M(+25.2%) | -$23.14 M(+42.9%) |
| Sep 2019 | - | -$5.54 M(-5.1%) | -$16.20 M(+52.0%) |
| Jun 2019 | - | -$5.84 M(+21.3%) | -$10.66 M(+121.3%) |
| Mar 2019 | - | -$4.82 M | -$4.82 M |
| Dec 2018 | -$19.10 M | - | - |
FAQ
- What is iTeos Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for iTeos Therapeutics?
- What is iTeos Therapeutics annual CFO year-on-year change?
- What is iTeos Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly CFO year-on-year change?
- What is iTeos Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for iTeos Therapeutics?
- What is iTeos Therapeutics TTM CFO year-on-year change?
What is iTeos Therapeutics annual cash flow from operations?
The current annual CFO of ITOS is -$103.76 M
What is the all time high annual CFO for iTeos Therapeutics?
iTeos Therapeutics all-time high annual cash flow from operations is $513.14 M
What is iTeos Therapeutics annual CFO year-on-year change?
Over the past year, ITOS annual cash flow from operations has changed by +$7.44 M (+6.69%)
What is iTeos Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ITOS is -$37.35 M
What is the all time high quarterly CFO for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly cash flow from operations is $605.00 M
What is iTeos Therapeutics quarterly CFO year-on-year change?
Over the past year, ITOS quarterly cash flow from operations has changed by -$23.59 M (-171.35%)
What is iTeos Therapeutics TTM cash flow from operations?
The current TTM CFO of ITOS is -$117.44 M
What is the all time high TTM CFO for iTeos Therapeutics?
iTeos Therapeutics all-time high TTM cash flow from operations is $566.49 M
What is iTeos Therapeutics TTM CFO year-on-year change?
Over the past year, ITOS TTM cash flow from operations has changed by -$13.69 M (-13.19%)